These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 384908)

  • 21. Selective isolation and rapid identification of Clostridium botulinum types A and B by toxin detection.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1985 Feb; 21(2):231-3. PubMed ID: 3882748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay.
    Doellgast GJ; Triscott MX; Beard GA; Bottoms JD; Cheng T; Roh BH; Roman MG; Hall PA; Brown JE
    J Clin Microbiol; 1993 Sep; 31(9):2402-9. PubMed ID: 8408563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Clostridium botulinum types C and D toxin by ELISA.
    Thomas RJ
    Aust Vet J; 1991 Mar; 68(3):111-3. PubMed ID: 2043084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.
    Wictome M; Newton K; Jameson K; Hallis B; Dunnigan P; Mackay E; Clarke S; Taylor R; Gaze J; Foster K; Shone C
    Appl Environ Microbiol; 1999 Sep; 65(9):3787-92. PubMed ID: 10473376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM; Modi NK; Roberts TA; Shone CC; Hambleton P; Melling J
    J Appl Bacteriol; 1987 Sep; 63(3):217-26. PubMed ID: 3323154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay (ELISA) for the detection and differentiation of Clostridium botulinum toxins type A and B.
    Michalik M; Grzybowski J; Ligieza J; Reiss J
    J Immunol Methods; 1986 Nov; 93(2):225-30. PubMed ID: 3095433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.
    Ashton AC; Crowther JS; Dolly JO
    Toxicon; 1985; 23(2):235-46. PubMed ID: 3895579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular structures and biological activities of Clostridium botulinum toxins.
    Sakaguchi G; Oishi I; Kozaki S; Sakaguchi S; Kitamura M
    Jpn J Med Sci Biol; 1974 Apr; 27(2):95-9. PubMed ID: 4601038
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid chemiluminescent slot blot immunoassay for the detection and quantification of Clostridium botulinum neurotoxin type E, in cultures.
    Cadieux B; Blanchfield B; Smith JP; Austin JW
    Int J Food Microbiol; 2005 May; 101(1):9-16. PubMed ID: 15878402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of Clostridium botulinum and botulinal toxin in food.
    Rodriguez A; Dezfulian M
    Folia Microbiol (Praha); 1997; 42(2):149-51. PubMed ID: 9306659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations.
    Ekong TA; McLellan K; Sesardic D
    J Immunol Methods; 1995 Mar; 180(2):181-91. PubMed ID: 7714333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked immunosorbent assay and enzyme-linked coagulation assay for detection of Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes with dual-label antibodies.
    Doellgast GJ; Beard GA; Bottoms JD; Cheng T; Roh BH; Roman MG; Hall PA; Triscott MX
    J Clin Microbiol; 1994 Jan; 32(1):105-11. PubMed ID: 8126163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colony immunoblot assay of botulinal toxin.
    Goodnough MC; Hammer B; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Jul; 59(7):2339-42. PubMed ID: 8357267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay in mice for low levels of Clostridium botulinum toxin.
    Takahashi M; Kameyama S; Sakaguchi G
    Int J Food Microbiol; 1990 Dec; 11(3-4):271-7. PubMed ID: 2149278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the outer membrane and toxin localization of Clostridium botulinum type E [proceedings].
    Ohyama A; Yabuuchi E; Ito T; Tanimura E; Yamamoto N
    Jpn J Med Sci Biol; 1978 Apr; 31(2):170-2. PubMed ID: 355685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.